We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $189M Turnover 22.11%
1-Year Est. Return 67.72%
This Fund
S&P 500
This Quarter Est. Return
+14.01%
1 Year Est. Return
+67.72%
3 Year Est. Return
+169.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$295M
AUM Growth
–
Cap. Flow
+$270M
Cap. Flow %
91.71%
Top 10 Hldgs %
52.03%
Holding
133
New
133
Increased
–
Reduced
–
Closed
–
Avg Time Held Equity + Options
0 years
Top 10 Avg Time Held Equity + Options
0 years
Top 20 Avg Time Held Equity + Options
0 years
Avg Time Held Equity only
0 years
Top 10 Avg Time Held Equity only
0 years
Top 20 Avg Time Held Equity only
0 years

Top Buys

Rank Stock Value
1
CLMT icon
Calumet Specialty Products
CLMT
+$49.7M
2
APO icon
Apollo Global Management
APO
+$18M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$16.2M
4
FTAI icon
FTAI Aviation
FTAI
+$12.7M
5
LGND icon
Ligand Pharmaceuticals
LGND
+$11.1M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 25.39%
2 Healthcare 22.98%
3 Materials 19.04%
4 Miscellaneous 10.96%
5 Communication Services 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
KAIR
26
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
$3.38M 1.15%
+345,463
New +$3.38M
2021 Q4
0 quarters
INCY icon
27
Incyte
INCY
$22.9B
$3.14M 1.07%
+42,820
New +$2.89M
2021 Q4
0 quarters
JAZZ icon
28
Jazz Pharmaceuticals
JAZZ
$13.6B
$2.98M 1.01%
+23,411
New +$3.08M
2021 Q4
0 quarters
VIP icon
29
Vulcan Infrastructure and Power
VIP
$24M
$2.97M 1.01%
+18,506
New +$3.88M
2021 Q4
0 quarters
GLHAW
30
DELISTED
Glass Houses Acquisition Corp. Warrant
GLHAW
$2.88M 0.98%
+250,000
New +$164K
2021 Q4
0 quarters
XENE icon
31
Xenon Pharmaceuticals
XENE
$3.24B
$2.7M 0.92%
+86,488
New +$2.58M
2021 Q4
0 quarters
BMY icon
32
Bristol-Myers Squibb
BMY
$122B
$2.64M 0.9%
+42,409
New +$2.49M
2021 Q4
0 quarters
AB icon
33
AllianceBernstein
AB
$3.21B
$2.47M 0.84%
+50,500
New +$2.64M
2021 Q4
0 quarters
ZGNX
34
DELISTED
Zogenix, Inc.
ZGNX
$2.19M 0.74%
+134,688
New +$1.97M
2021 Q4
0 quarters
AVDL
35
DELISTED
Avadel Pharmaceuticals
AVDL
$2.09M 0.71%
+258,198
New +$2.36M
2021 Q4
0 quarters
HZNP
36
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.05M 0.69%
+19,000
New +$2.07M
2021 Q4
0 quarters
JPM icon
37
JPMorgan Chase
JPM
$902B
$2.05M 0.69%
+12,920
New +$2.12M
2021 Q4
0 quarters
INVA icon
38
Innoviva
INVA
$1.5B
$1.99M 0.67%
+115,269
New +$1.96M
2021 Q4
0 quarters
PMGM icon
39
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
$1.98M 0.67%
+200,000
New +$1.97M
2021 Q4
0 quarters
TWLVW icon
40
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
$1.98M 0.67%
+171,666
New +$108K
2021 Q4
0 quarters
DNMR icon
41
DELISTED
Danimer Scientific, Inc.
DNMR
$1.7M 0.58%
+5,000
New +$2.75M
2021 Q4
0 quarters
KAIRW
42
DELISTED
Kairos Acquisition Corp. Warrant
KAIRW
$1.68M 0.57%
+146,528
New +$85.6K
2021 Q4
0 quarters
EIGR
43
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.65M 0.56%
+10,583
New +$2.05M
2021 Q4
0 quarters
CHRS icon
44
Coherus Oncology
CHRS
$153M
$1.64M 0.56%
+102,555
New +$1.79M
2021 Q4
0 quarters
ABBV icon
45
AbbVie
ABBV
$504B
$1.35M 0.46%
+10,000
New +$1.18M
2021 Q4
0 quarters
BRIVW
46
DELISTED
B. Riley Principal 250 Merger Corp. Warrant
BRIVW
$1.34M 0.46%
+116,666
New +$120K
2021 Q4
0 quarters
PMGMW icon
47
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
$1.15M 0.39%
+100,000
New +$62.7K
2021 Q4
0 quarters
RHP icon
48
Ryman Hospitality Properties
RHP
$8.69B
$1.14M 0.39%
+12,400
New +$1.06M
2021 Q4
0 quarters
MDLZ icon
49
Mondelez International
MDLZ
$81.6B
$995K 0.34%
+15,000
New +$926K
2021 Q4
0 quarters
QTEK
50
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
$992K 0.34%
+100,000
New +$993K
2021 Q4
0 quarters
1
2
3 4 5

Similar funds

SCA
Sander Capital Advisors Seattle, Washington $189M AUM 13.06% 1-Year Est. Return
FI
FWG Investments Lexington, Kentucky $189M AUM 18.47% 1-Year Est. Return
MFS
Madrid Financial Services Manhattan Beach, California $189M AUM 30.12% 1-Year Est. Return
FRA
FFG Retirement Advisors Centennial, Colorado $189M AUM 16.39% 1-Year Est. Return
CAM
Councilmark Asset Management Knoxville, Tennessee $189M AUM 26.93% 1-Year Est. Return
BAG
Bauman Advisory Group Las Vegas, Nevada $189M AUM
SHC
SALT Holding Corp Wilmington, Delaware $189M AUM 34.63% 1-Year Est. Return
HC
Hara Capital Bellevue, Washington $190M AUM 42.56% 1-Year Est. Return

David M. Knott Jr's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for David M. Knott Jr, which disclosed 133 positions worth $295M. Its ten largest holdings account for 52% of the portfolio.

Its largest position is Calumet Specialty Products: 3,952,000 shares worth $52.2M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, followed by Healthcare and Materials.

  • David M. Knott Jr's largest Q4 2021 buy was Calumet Specialty Products: 3,952,000 shares worth $52.2M.
  • David M. Knott Jr's ten largest holdings make up 52% of its $295M portfolio in Q4 2021.
  • David M. Knott Jr disclosed 133 positions in Q4 2021, its first 13F filing on record.

Based on David M. Knott Jr's 13F filing for Q4 2021, filed 11 Feb 2022.